Gary B. Gordon, Chief Medical Officer at Ayala Pharmaceuticals, Inc. (AYLA), sold 3,000 shares at $15.03 ($45K) on 2021-01-20, disclosed to the SEC on 2021-01-22.
Scheduled sale ($45k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AYLA | SELL | 2021-02-26 | $52K | — | Filing → |